Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
ABN AMRO BK.UNSP.ADR/1 | AB2A | 6. nov 2024 | 14.90 | -1.32 |
ABO Wind AG | AB9 | 6. nov 2024 | 40.00 | -7.62 |
ABO-Group | 3T61 | 6. nov 2024 | 5.25 | +0.96 |
ABOUT YOU HOLDING AG | YOU | 6. nov 2024 | 3.35 | +0.90 |
Absa Group Limited | AU61 | 6. nov 2024 | 8.80 | -0.57 |
ABSOLICON SOLAR COLLEC. B | ZY0 | 6. nov 2024 | 0.38 | +5.29 |
AC Immune SA | IMR | 6. nov 2024 | 3.00 | +8.11 |
Acacia Research Corporation | AZG2 | 6. nov 2024 | 4.12 | +3.52 |
AcadeMedia | V8T | 6. nov 2024 | 5.57 | -0.36 |
Acadia Healthcare Company, Inc. | 7RA | 6. nov 2024 | 40.00 | +3.63 |
ACADIA Pharmaceuticals Inc. | DR6 | 6. nov 2024 | 14.03 | +5.53 |
Acadia Realty Trust | WX1 | 6. nov 2024 | 23.20 | +2.65 |
Acadian Timber Corp | 779 | 6. nov 2024 | 12.20 | +6.09 |
Acanthe Developpement SA | ADX | 6. nov 2024 | 0.32 | 0.00 |
Acarix | 7AC | 6. nov 2024 | 0.02 | -0.81 |
Acast AB | 0PN | 6. nov 2024 | 1.39 | +4.91 |
Acasti Pharma A | A1P0 | 6. nov 2024 | 2.78 | 0.00 |
Accelerate Diagnostics | 1A80 | 6. nov 2024 | 1.73 | +6.79 |
ACCELLERON IND. ADR/1 | ZH20 | 6. nov 2024 | 54.50 | +12.60 |
Accent Resources NL | A2R | 6. nov 2024 | 0.01 | 0.00 |
Accentis S.A. | D1Z | 6. nov 2024 | 0.02 | -9.09 |
Accentro Real Estate AG | A4Y | 6. nov 2024 | 0.34 | -10.11 |
Accenture plc Class A Ordinary Shares (Ireland) | CSA | 6. nov 2024 | 331.85 | +4.31 |
Accesso Technology Group Plc | LQG | 6. nov 2024 | 5.95 | +0.85 |
Acciona SA | AJ3 | 6. nov 2024 | 110.30 | -8.92 |
Acco Brands Corporation | A3B | 6. nov 2024 | 5.45 | +7.92 |
Accolade, Inc. | 4NE1 | 6. nov 2024 | 3.00 | +6.38 |
Acconeer | 2LU | 6. nov 2024 | 0.45 | -0.78 |
Accor | ACR1 | 6. nov 2024 | 8.35 | +1.21 |
Accor SA | ACR | 6. nov 2024 | 41.96 | +1.57 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.